Transcriptional signatures of fentanyl use in the mouse ventral tegmental area
Addiction Biology · 2024
DOI: 10.1111/adb.13403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction Biology, 2024. Verfasst von Megan E Fox und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Ventral Tegmental Area, Fentanyl, Analgesics, Opioid, Mice, Inbred C57BL. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Synthetic opioids such as fentanyl contribute to the vast majority of opioid‐related overdose deaths, but fentanyl use remains broadly understudied. Like other substances with misuse potential, opioids cause lasting molecular adaptations to brain reward circuits, including neurons in the ventral tegmental area (VTA). The VTA contains numerous cell types that play diverse roles in opioid use and relapse; however, it is unknown how fentanyl experience alters the transcriptional landscape in specific subtypes. Here, we performed single nuclei RNA sequencing to study transcriptional programs in fentanyl‐experienced mice. Male and female C57/BL6 mice self‐administered intravenous fentanyl (1.5 μg/kg/infusion) or saline for 10 days. After 24 h abstinence, VTA nuclei were isolated and prepared for sequencing on the 10× platform. We identified different patterns of gene expression across cell types. In dopamine neurons, we found enrichment of genes involved in growth hormone signalling. In dopamine‐glutamate‐GABA combinatorial neurons, and some GABA neurons, we found enrichment of genes involved in Pi3k‐Akt signalling. In glutamate neurons, we found enrichment of genes involved in cholinergic signalling. We identified transcriptional regulators for the differentially expressed genes in each neuron cluster, including downregulated transcriptional repressor Bcl6, and upregulated transcription factor Tcf4. We also compared the fentanyl‐induced gene expression changes identified in mouse VTA with a published rat dataset in bulk VTA, and found overlap in genes related to GABAergic signalling and extracellular matrix interaction. Together, we provide a comprehensive picture of how fentanyl self‐administration alters the transcriptional landscape of the mouse VTA that serves as the foundation for future mechanistic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
- Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
- Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Megan E Fox
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Fox, M. E., Montemarano, A., Ostman, A. E., Basu, M., Herb, B., Ament, S. A., & Fox, L. D. (2024). Transcriptional signatures of fentanyl use in the mouse ventral tegmental area. Addiction Biology. https://doi.org/10.1111/adb.13403
Vancouver
Fox ME, Montemarano A, Ostman AE, Basu M, Herb B, Ament SA, et al. Transcriptional signatures of fentanyl use in the mouse ventral tegmental area. Addiction Biology. 2024. doi:10.1111/adb.13403
BibTeX
@article{Fox2024,
author = {Fox, Megan E and Montemarano, Annalisa and Ostman, Alexandria E and Basu, Mahashweta and Herb, Brian and Ament, Seth A and Fox, Logan D},
title = {Transcriptional signatures of fentanyl use in the mouse ventral tegmental area},
journal = {Addiction Biology},
year = {2024},
doi = {10.1111/adb.13403}
}
EUVIMED